novel
swineorigin
influenza
viru
rapidli
spread
china
mani
countri
around
world
prompt
world
health
organ
declar
pandem
june
first
case
infect
china
report
may
sinc
number
case
continu
increas
march
laboratoryconfirm
case
report
differ
provinc
includ
death
symptomat
care
antivir
therapi
main
treatment
neuraminidas
inhibitor
oseltamivir
zanamivir
recommend
patient
high
risk
develop
sever
progress
clinic
ill
howev
grow
evid
neuraminidas
inhibitor
resist
influenza
virus
chines
herbal
medicin
chm
long
histori
use
treatment
infecti
diseas
chm
theoret
system
mani
import
scientif
contribut
shang
han
za
bing
lun
wenb
tiaobian
chm
wide
use
cold
influenza
clinic
practic
china
time
sever
acut
respiratori
syndrom
outbreak
studi
reveal
evid
potenti
posit
effect
chm
provid
valuabl
inform
regard
treatment
influenza
moreov
earli
stage
outbreak
clinic
practic
outcom
indic
chm
potenti
effect
allevi
symptom
shorten
cours
treatment
therefor
chm
may
promis
altern
complementari
therapi
influenza
howev
concret
clinic
evid
need
demonstr
effect
present
studi
began
decemb
china
support
chines
govern
program
clinic
research
pandem
influenza
treat
chm
aim
studi
determin
chines
physician
treat
patient
influenzalik
ill
clinic
practic
compar
effect
differ
treatment
influenza
multisit
observ
studi
conduct
outbreak
china
decemb
april
studi
conduct
hospit
includ
chines
medicin
hospit
gener
hospit
infecti
diseas
hospit
provinc
differ
region
studi
conduct
supervis
guangdong
provinci
hospit
chines
medicin
gphcm
enrol
particip
observ
follow
diseas
cours
observ
followup
ceas
within
day
end
treatment
studi
regist
februari
chines
clinic
trial
registri
http
wwwchictrorgcn
elig
particip
outpati
diagnos
suspect
influenza
either
clinic
base
laboratori
test
accord
guidelin
releas
chines
ministri
health
physician
prescrib
medic
accord
patient
condit
studi
control
treatment
prescrib
physician
select
chm
convent
treatment
refer
guidelin
releas
chines
ministri
health
differ
treatment
defin
follow
chm
tradit
medic
practic
china
diagnosi
system
treatment
principl
defin
use
decoct
product
chines
patent
medicin
least
three
time
cours
diseas
studi
b
convent
treatment
convent
medic
practic
base
western
medicin
principl
studi
includ
symptomat
treatment
routin
convent
treatment
reliev
symptom
fever
cough
phlegm
product
antivir
treatment
routin
use
antivir
drug
oseltamivir
least
cours
diseas
antibiot
includ
found
doctor
prescrib
antibiot
patient
influenza
c
combin
treatment
defin
studi
chm
plu
convent
treatment
primari
outcom
includ
time
allevi
symptom
incid
complic
time
allevi
symptom
defin
number
day
date
patient
visit
doctor
baselin
date
date
main
symptom
allevi
h
main
symptom
includ
nasal
congest
sore
throat
cough
myalgia
fatigu
headach
fourlevel
scale
use
evalu
symptom
none
mild
moder
sever
possibl
complic
includ
bronchiti
pneumonia
tonsillar
abscess
sever
complic
describ
guidelin
secondari
outcom
follow
time
becom
afebril
defin
number
hour
time
patient
visit
doctor
time
temperatur
drop
period
h
b
incid
sever
ill
due
influenza
character
follow
symptom
sign
high
fever
last
b
heavi
cough
purul
sputum
bloodi
sputum
chest
pain
c
rapid
breath
difficult
breath
cyanosi
lip
alter
mental
statu
blunt
respons
sensibl
drowsi
dysphoria
convuls
e
sever
vomit
diarrhea
dehydr
f
sign
pneumonia
imag
examin
g
rapid
increas
myocardi
enzym
creatin
phosphokinas
ck
creatin
kinas
isoenzym
ckmb
h
aggrav
exist
physic
ill
c
neg
result
influenza
viral
test
total
medic
fee
includ
medic
fee
clinic
fee
patient
demograph
data
vaccin
histori
histori
recent
contact
patient
influenza
histori
seriou
medic
problem
medic
treatment
cost
record
influenzalik
symptom
assess
studi
also
collect
laboratori
test
result
avail
vital
sign
blood
test
result
urin
test
result
liver
function
test
result
renal
function
test
result
electrocardiogram
find
chest
radiographi
find
influenza
viru
rapid
test
result
influenza
viru
test
result
predevelop
case
report
form
use
collect
data
patient
requir
record
symptom
bodi
temperatur
medic
taken
daili
diari
research
follow
patient
via
telephon
call
andor
inperson
interview
day
maximum
treatment
patient
withdrawn
studi
condit
becam
sever
die
influenza
caus
physician
variou
center
train
studi
independ
organ
guangdong
intern
clinic
research
center
chines
medicin
conduct
data
monitor
case
report
form
center
deliv
gphcm
review
eight
data
entri
oper
train
doubl
entri
epidata
softwar
epidata
associ
odens
denmark
databas
lock
data
clean
sampl
size
calcul
assum
time
allevi
symptom
main
outcom
chm
treatment
convent
treatment
combin
treatment
standard
deviat
accord
data
pilot
studi
use
analysi
varianc
compar
outcom
group
power
signific
level
found
patient
need
studi
pass
softwar
ncss
kaysvil
ut
usa
use
calcul
sampl
size
miss
data
regard
symptom
bodi
temperatur
replac
last
observ
carri
forward
locf
particip
taken
medicin
undergon
collect
outcom
data
least
analyz
pasw
statist
softwar
packag
spss
inc
chicago
il
usa
stata
softwar
stata
corp
colleg
station
tx
usa
use
statist
analysi
either
ttest
mannwhitney
test
use
compar
continu
variabl
two
group
oneway
analysi
varianc
correspond
nonparametr
kruskalw
test
use
compar
continu
variabl
two
group
test
use
compar
categor
variabl
control
confound
differ
group
either
binari
ordin
logist
regress
model
perform
compar
time
allevi
symptom
time
becom
afebril
categor
either
h
incid
complic
sever
ill
probabl
test
neg
influenza
viral
test
group
baselin
variabl
select
covari
multivari
regress
model
pvalu
total
medic
fee
compar
group
gener
linear
model
final
regress
model
paramet
estim
adjust
confound
variabl
cluster
sampl
hospit
level
pvalu
consid
statist
signific
final
model
influenza
outbreak
decemb
april
potenti
elig
outpati
influenzalik
ill
visit
fever
clinic
emerg
room
hospit
provinc
region
china
total
patient
enrol
studi
screen
patient
discontinu
treatment
immedi
prescript
lost
followup
first
visit
therefor
patient
exclud
analysi
lack
data
evalu
treatment
effect
final
analysi
includ
data
patient
chm
group
convent
treatment
group
combin
treatment
group
flow
chart
studi
shown
figur
number
elig
patient
hospit
rang
shown
figur
baselin
characterist
patient
chm
group
convent
treatment
group
combin
treatment
group
shown
tabl
chm
alon
combin
use
frequent
convent
treatment
patient
histori
seriou
medic
problem
mean
age
patient
year
mean
bodi
temperatur
baselin
patient
receiv
influenza
vaccin
studi
influenza
viru
rapid
test
posit
rate
among
patient
took
test
baselin
variabl
except
sex
diastol
blood
pressur
influenza
vaccin
sore
throat
cough
unbalanc
group
p
one
aim
studi
collect
data
physician
treat
patient
influenza
tabl
see
percentag
patient
prescrib
chm
alon
total
prescrib
convent
treatment
prescrib
combin
treatment
examin
treatment
data
studi
calcul
frequenc
chm
symptomat
treatment
antivir
treatment
combin
tabl
number
patient
least
one
follow
medic
use
follow
chm
symptomat
treatment
antivir
treatment
antibiot
treatment
evalu
concomit
diseas
patient
accept
antibiot
treatment
found
patient
need
antibiot
infecti
diseas
therefor
irrat
use
antibiot
influenza
may
occur
patient
chm
combin
symptomat
treatment
common
treatment
nearli
onethird
patient
receiv
chm
treatment
alon
rate
use
chm
chines
medicin
hospit
nonchines
medicin
hospit
respect
mean
time
allevi
symptom
respect
chm
group
convent
treatment
group
combin
treatment
group
allevi
symptom
primarili
occur
fifth
day
symptom
patient
disappear
time
ordin
logist
regress
model
use
adjust
confound
factor
compar
effect
among
three
treatment
group
tabl
depend
variabl
number
day
allevi
symptom
start
treatment
shown
tabl
adjust
cluster
effect
statist
signific
differ
convent
treatment
group
two
group
addit
patient
influenza
vaccin
histori
recent
contact
patient
influenza
cough
higher
temperatur
need
day
recov
symptom
mean
time
becom
afebril
h
chm
group
convent
treatment
group
combin
treatment
group
respect
half
patient
becam
afebril
within
h
treatment
result
shown
tabl
indic
signific
differ
found
chm
chm
group
combin
treatment
group
convent
treatment
patient
sever
influenza
occur
case
chm
group
case
convent
treatment
group
case
combin
treatment
note
chm
chines
herbal
medicin
sbp
systol
blood
pressur
dbp
diastol
blood
pressur
sd
standard
deviat
total
symptom
score
score
none
mild
moder
sever
assign
six
main
symptom
nasal
congest
sore
throat
cough
myalgia
fatigu
headach
total
symptom
score
particip
obtain
sum
score
six
symptom
group
binari
logist
regress
analysi
tabl
show
statist
signific
among
three
group
patient
test
posit
influenza
viru
rapid
test
baselin
test
posit
fifth
day
treatment
total
patient
test
neg
patient
confirm
viru
baselin
retest
treatment
patient
test
neg
treatment
proport
miss
data
high
outcom
perform
comparison
among
group
mean
total
medic
fee
studi
usd
chm
group
convent
treatment
group
combin
treatment
group
gener
linear
model
use
compar
fee
among
three
group
unadjust
adjust
estim
differ
significantli
among
three
group
sex
histori
seriou
medic
problem
height
weight
systol
blood
pressur
puls
rate
respir
temperatur
total
symptom
score
baselin
adjust
model
fee
found
statist
signific
p
bivari
analysi
singlefactor
analysi
tabl
show
signific
differ
found
comparison
total
medic
fee
among
three
group
chm
treatment
econom
two
treatment
total
case
advers
event
report
among
patient
case
diarrhea
case
vomit
case
combin
diarrhea
vomit
case
allerg
reaction
case
syncop
case
tinnitu
case
includ
mild
moder
advers
event
eight
case
chm
group
combin
treatment
group
studi
perform
analyz
clinic
treatment
patient
influenzalik
ill
china
compar
effect
differ
influenza
treatment
especi
chm
studi
show
chm
use
extens
hospit
focus
chines
medicin
chm
combin
symptomat
treatment
main
form
therapi
influenzalik
ill
clinic
practic
especi
patient
sever
symptom
chm
alon
combin
western
medicin
use
frequent
convent
treatment
patient
histori
seriou
medic
problem
find
differ
studi
titl
treatment
influenza
chines
medicin
vs
western
medicin
accord
studi
patient
mild
ill
prefer
chines
tradit
medicin
treatment
symptom
specif
fever
western
medicin
prefer
patient
complic
ill
appear
comprehens
effect
herbal
medicin
limit
evid
support
claim
time
author
arriv
conclus
clue
base
patient
choic
studi
provid
evid
base
data
time
tradit
chines
medicin
use
convent
treatment
resum
clinic
practic
studi
signific
differ
found
time
allevi
symptom
incid
complic
time
becom
afebril
rate
sever
ill
among
chm
convent
treatment
combin
treatment
group
howev
signific
differ
found
total
medic
fee
among
three
group
chm
treatment
econom
two
treatment
recent
year
sever
clinic
studi
perform
evalu
efficaci
chm
includ
studi
lianhuaqingwen
capsul
maxingshiganyinqiaosan
two
form
chm
demonstr
potenti
posit
effect
howev
systemat
review
determin
confirm
conclus
benefici
effect
chines
herb
influenza
could
reach
lack
placebocontrol
trial
repeat
intervent
test
two
systemat
review
chm
influenza
also
show
chm
potenti
posit
effect
treatment
influenza
current
evid
remain
weak
therefor
chm
yet
show
clear
advantag
convent
treatment
treatment
influenza
one
strength
studi
larg
number
patient
influenzalik
ill
enrol
outbreak
influenza
china
furthermor
sampl
collect
cover
region
china
anoth
strength
power
primari
outcom
mean
neg
result
signific
differ
unlik
due
small
sampl
size
chanc
main
limit
studi
observ
studi
without
control
group
thu
difficult
isol
efficaci
three
treatment
sampl
three
group
random
therefor
uneven
even
tri
adjust
possibl
confound
analysi
might
overlook
sever
thu
bias
result
conclus
although
chm
better
effect
influenza
convent
treatment
econom
find
serv
overview
treatment
influenzalik
ill
use
chm
china
provid
basi
futur
research
topic
futur
random
control
trial
conduct
evalu
confirm
find
